Eduardo Edelman Saul (Eduardo Saul, Eduardo E Saul)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 5

Top Topics

Prognostic Factors

Radiation Therapy

Top Venues

JCO oncology practice

Leukemia & lymphoma

This page only lists publications with an associated author ORCID identifier.

Publications

Eduardo Edelman Saul, Juan Pablo Alderuccio, Isildinha M Reis, Wei Zhao, Sunil Girish Iyer, Gregor Rodriguez, Amrita Desai, Jennifer R Chapman, David T Tse, Arnold M Markoe, Derek M Isrow, Izidore S Lossos
Long-term outcomes of patients with conjunctival extranodal marginal zone lymphoma. American journal of hematology (2022)
Laercio Lopes da Silva, Pedro Nazareth Aguiar, Robin Park, Eduardo Edelman Saul, Benjamin Haaland, Gilberto de Lima Lopes
Comparative Efficacy and Safety of Programmed Death-1 Pathway Inhibitors in Advanced Gastroesophageal Cancers: A Systematic Review and Network Meta-Analysis of Phase III Clinical Trials. Cancers 13 (11) (2021)
Sunil Girish Iyer, Russ A Kuker, Jorge A Florindez, Eduardo Edelman Saul, Asaad Trabolsi, Gregor Rodriguez, Jennifer R Chapman, Izidore S Lossos, Juan Pablo Alderuccio
A single-center analysis of patients with extranodal marginal zone lymphoma of the breast. Leukemia & lymphoma (2021)
Philippos Apolinario Costa, Eduardo Edelman Saul, Yonette Paul, Sunil Girish Iyer, Laercio Lopes da Silva, Leonardo Tamariz, Gilberto Lopes
Prevalence of Targetable Mutations in Black Patients With Lung Cancer: A Systematic Review and Meta-Analysis. JCO oncology practice 17 (5) (2021)
Eduardo Edelman Saul, Raquel B Guerra, Michelle Edelman Saul, Laercio Lopes da Silva, Gabriel F P Aleixo, Raquel M K Matuda, Gilberto Lopes
The challenges of implementing low-dose computed tomography for lung cancer screening in low- and middle-income countries. Nature cancer 1 (12) (2020)